非洲裔与青光眼评估研究(ADAGES)III:基因型对非洲裔美国人青光眼表型的贡献——研究设计与基线数据
ADAGES III为横断面病例对照研究,从美国5个研究中心招募3266名非洲裔或欧洲裔青光眼患者及非青光眼对照,采集人口学、医学史、血压、唾液与血样及眼科检查数据,描述基线特征。校正年龄后,非洲裔原发性开角型青光眼(POAG)患者较欧洲裔患者眼压更高、视力与视野平均偏差更差、角膜更薄(均P<0.001),而青光眼家族史无差异。该基因组学研究旨在填补该高风险人群POAG遗传学知识空白。
要点
- ADAGES III纳入3266名非洲裔或欧洲裔POAG患者及对照,来自美国5个研究中心。
- 校正年龄后,非洲裔POAG患者眼压更高、视力及视野平均偏差更差、角膜更薄(均P<0.001)。
- 非洲裔与欧洲裔POAG患者的青光眼家族史无差异。
核心结论
- ADAGES III基因组学研究凭借大样本、广泛标本采集及对来自美国不同地区的非洲裔与欧洲裔青光眼患者和对照的深度表型分析,将填补该高风险人群POAG遗传学知识空白。
研究设计与样本
- 横断面病例对照研究,从美国5个不同地区的研究中心招募3266名非洲裔或欧洲裔青光眼患者及非青光眼对照。
主要发现
- 3266名参与者包括2146名非洲裔POAG患者、695名欧洲裔POAG患者、198名非洲裔对照和227名欧洲裔对照。
- 非洲裔POAG患者和非洲裔对照均显著更年轻(均为67.4岁),欧洲裔POAG患者和欧洲裔对照分别为73.4岁和70.2岁。
- 校正年龄后,非洲裔POAG患者较欧洲裔POAG患者眼压更高、视力更差、视野平均偏差更差、角膜更薄(均P<0.001)。
- 非洲裔与欧洲裔POAG患者的青光眼家族史无差异。
关键数值与推荐
- 非洲裔POAG患者与非洲裔对照年龄均为67.4岁,欧洲裔POAG患者73.4岁、欧洲裔对照70.2岁。
- 校正年龄后非洲裔与欧洲裔POAG患者眼压、视力、视野平均偏差及角膜厚度差异均P<0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the study protocol and baseline characteristics of the African Descent and Glaucoma Evaluation Study (ADAGES) III. DESIGN: Cross-sectional, case-control study. PARTICIPANTS: Three thousand two hundred sixty-six glaucoma patients and control participants without glaucoma of African or European descent were recruited from 5 study centers in different regions of the United States. METHODS: Individuals of African descent (AD) and European descent (ED) with primary open-angle glaucoma (POAG) and control participants completed a detailed demographic and medical history interview. Standardized height, weight, and blood pressure measurements were obtained. Saliva and blood samples to provide serum, plasma, DNA, and RNA were collected for standardized processing. Visual fields, stereoscopic disc photographs, and details of the ophthalmic examination were obtained and transferred to the University of California, San Diego, Data Coordinating Center for standardized processing and quality review. MAIN OUTCOME MEASURES: Participant gender, age, race, body mass index, blood pressure, history of smoking and alcohol use in POAG patients and control participants were described. Ophthalmic measures included intraocular pressure, visual field mean deviation, central corneal thickness, glaucoma medication use, or past glaucoma surgery. Ocular conditions, including diabetic retinopathy, age-related macular degeneration, and past cataract surgery, were recorded. RESULTS: The 3266 ADAGES III study participants in this report include 2146 AD POAG patients, 695 ED POAG patients, 198 AD control participants, and 227 ED control participants. The AD POAG patients and control participants were significantly younger (both, 67.4 years) than ED POAG patients and control participants (73.4 and 70.2 years, respectively). After adjusting for age, AD POAG patients had different phenotypic characteristics compared with ED POAG patients, including higher intraocular pressure, worse visual acuity and visual field mean deviation, and thinner corneas (all P < 0.001). Family history of glaucoma did not differ between AD and ED POAG patients. CONCLUSIONS: With its large sample size, extensive specimen collection, and deep phenotyping of AD and ED glaucoma patients and control participants from different regions in the United States, the ADAGES III genomics study will address gaps in our knowledge of the genetics of POAG in this high-risk population.
引用
- Zangwill LM, Ayyagari R, Liebmann JM, et al. The African Descent and Glaucoma Evaluation Study (ADAGES) III: Contribution of Genotype to Glaucoma Phenotype in African Americans: Study Design and Baseline Data. Ophthalmology. 2018. PMID: 29361356. doi:10.1016/j.ophtha.2017.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。